Akebia Therapeutics shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Akebia Therapeutics (AKBA) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Akebia Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Akebia Therapeutics held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Akebia Therapeutics by Ubs Global Asset Management Americas
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $893k | 327k | 2.73 |
| 2025-06-30 | $99k | 27k | 3.64 |
| 2022-03-31 | $130k | 181k | 0.72 |
| 2021-12-31 | $409k | 181k | 2.26 |
| 2021-09-30 | $502k | 174k | 2.88 |
| 2021-06-30 | $753k | 199k | 3.79 |
| 2021-03-31 | $316k | 93k | 3.39 |
| 2020-12-31 | $221k | 88k | 2.51 |
| 2020-09-30 | $221k | 88k | 2.51 |
| 2020-06-30 | $1.2M | 89k | 13.58 |
| 2020-03-31 | $600k | 79k | 7.58 |
| 2019-12-31 | $528k | 84k | 6.32 |
| 2019-09-30 | $315k | 80k | 3.92 |
| 2019-06-30 | $362k | 75k | 4.84 |
| 2019-03-31 | $520k | 64k | 8.19 |
| 2018-12-31 | $225k | 41k | 5.53 |
| 2018-09-30 | $157k | 18k | 8.83 |
| 2018-06-30 | $178k | 18k | 9.98 |
| 2018-03-31 | $170k | 18k | 9.53 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas